CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. Prevention of skin cancer and reduction of keratotic skin lesions during ...

Engraftment kinetics in BM or PBSC transplantation (PBSCT) depends on the number and efficiency of stem cells in the graft. Currently, stem cell evaluation is performed by counting CD34+ cells.

October 24, 2011 — In nonstraightforward bone marrow analysis, the presence of 30% or more CD34+ megakaryocytes is a strong indicator of megaloblastic anemia or a myeloid neoplasm, according to a ...

Repetitive Cycles of High-Dose Cytarabine Benefit Patients With Acute Myeloid Leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461 Thirteen patients (MM, n = 7; NHL, n = 6) ...

Expanding on the Cooperative Center of Excellence in Hematology (CCEH) at Fred Hutchinson Cancer Center’s expertise in providing Human CD34+ HSPCs, we have established a high-efficiency and ...

Epoch-Making Breakthrough of the Stem-Cell Nutritional Supplementation CD34 Nu-Signals®, Currently Undergoing Rigorous Clinical Trials Conducted by Prestigious Medical Institutions to Validate Its ...

CAMBRIDGE, Mass. & HAIFA, Israel--(BUSINESS WIRE)--Minovia Therapeutics, a clinical-stage company focused on the development of cell-based Mitochondrial Augmentation Technology (MAT) to treat ...

Polycythemia vera is the ultimate phenotypic consequence of the V617F mutation in Janus kinase 2 (encoded by JAK2), but the extent to which this mutation influences the behavior of the involved CD34+ ...

Timely donor lymphocyte infusion (DLI) following the detection of impending molecular relapse may significantly improve outcomes for patients with acute myeloid leukemia (AML) who undergo allogeneic ...

CAMBRIDGE, Mass. & BERGISCH GLADBACH, Germany--(BUSINESS WIRE)--Miltenyi Biotec announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s CliniMACS CD34 Reagent ...